Two cases of bullous pemphigoid effectively treated with oral tofacitinib.

Youssef, Soundos; Gallitano, Stephanie; Bordone, Lindsey A

Youssef, Soundos; Gallitano, Stephanie; Bordone, Lindsey A.

Affiliation

Youssef S; Postdoctoral Research Fellow, Department of Dermatology, Columbia University Irving Medical Center, New York, New York.
Gallitano S; Assistant Professor, Department of Dermatology, Columbia University Irving Medical Center, New York, New York.
Bordone LA; Assistant Professor, Department of Dermatology, Columbia University Irving Medical Center, New York, New York.

JAAD Case Rep ; 32: 77-80, 2023 Feb.

Article in En | MEDLINE | ID: mdl-36691585

Key words

BP, bullous pemphigoid; JAK inhibitor; JAK, Janus kinase; JAKi, Janus kinase inhibitor; Janus kinase inhibitor; STAT, signal transducers and activators of transcription; bullous pemphigoid; tofacitinib; treatment efficacy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JAAD Case Rep Year: 2023 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JAAD Case Rep Year: 2023 Document type: Article